DexCom (DXCM) vs Koninklijke Philips N.V. NY Registry Shares (PHG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
DexCom (DXCM) has outperformed Koninklijke Philips N.V. NY Registry Shares (PHG) over the past year, gaining 27.7% versus a loss of 13.4%. Over five years, DXCM leads with a -38.1% price change compared with -46.0% for PHG. DexCom is the larger company by market cap ($31.65 billion vs $23.67 billion), about 1.3 times the size.
On valuation, Koninklijke Philips N.V. NY Registry Shares trades at a lower forward P/E (12.8x vs 26.8x for DexCom). Koninklijke Philips N.V. NY Registry Shares pays a dividend yielding 3.51%, while DexCom does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DXCM | PHG |
|---|---|---|
| Share price | $83.88 | $24.22 |
| Market cap | $31.65B | $23.67B |
| 1-day change | -0.50% | +0.54% |
| YTD return | +27.02% | -11.04% |
| 1-year return | +27.67% | -13.44% |
| 5-year return | -38.07% | -45.95% |
| P/E ratio (TTM) | 33.29 | 18.07 |
| Forward P/E | 26.83 | 12.79 |
| EPS (TTM) | $2.52 | $1.34 |
| Dividend yield | 0.00% | 3.51% |
| Annual dividend | $0.00 | $0.85 |
| Revenue (latest FY) | $4.66B | — |
| Revenue growth (YoY) | +15.60% | — |
| Net income (latest FY) | $836.30M | — |
| Gross margin | 60.10% | — |
| Operating margin | 19.56% | — |
| Net margin | 17.94% | — |
| 52-week high | $92.59 | $33.44 |
| 52-week low | $54.11 | $23.62 |
| Distance from 52-week high | -9.41% | -27.57% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +14.72% | +32.20% |
| Average volume | 4.44M | 994.93K |
| Shares outstanding | 377.36M | 977.43M |
| Employees | 11,000 | 63,670 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical Electronics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DXCM has outperformed PHG by 41.1 percentage points over the past year.
- DexCom trades at a higher earnings multiple (33.3x vs 18.1x trailing P/E).
- Koninklijke Philips N.V. NY Registry Shares offers a meaningfully higher dividend yield (3.51% vs 0.00%).
About DexCom
DXCM stock →DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application.
Health Care · Medical/Dental Instruments · 11,000 employees
About Koninklijke Philips N.V. NY Registry Shares
PHG stock →Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Health Care · Medical Electronics · 63,670 employees
DXCM vs PHG FAQ
Which is bigger, DexCom or Koninklijke Philips N.V. NY Registry Shares?
DexCom (DXCM) is larger, with a market capitalization of $31.65B compared with $23.67B for Koninklijke Philips N.V. NY Registry Shares (PHG).
Which stock has performed better over the past year, DXCM or PHG?
DXCM returned +27.67% over the past 12 months, compared with -13.44% for PHG (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DXCM or PHG?
PHG has the lower trailing P/E at 18.1, versus 33.3 for DXCM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, DexCom or Koninklijke Philips N.V. NY Registry Shares?
Koninklijke Philips N.V. NY Registry Shares pays a dividend yielding 3.51%, while DexCom does not currently pay a regular dividend.
Are DexCom and Koninklijke Philips N.V. NY Registry Shares in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for DexCom and Medical Electronics for Koninklijke Philips N.V. NY Registry Shares.